SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein
Por um escritor misterioso
Descrição
Abstract Pilomatricomas are benign tumors originating from the capillary matrix, which may
![SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00280-021-04274-6/MediaObjects/280_2021_4274_Fig2_HTML.png)
Population pharmacokinetics and exposure–response of selumetinib and its N‐desmethyl metabolite in pediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas
![SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00277-021-04534-8/MediaObjects/277_2021_4534_Fig2_HTML.png)
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US
![SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Ftpj.2010.85/MediaObjects/41397_2012_Article_BFtpj201085_Fig1_HTML.jpg)
CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans
![SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-018-0154-8/MediaObjects/41408_2018_154_Fig1_HTML.png)
Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I Study
![SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein](https://minio.scielo.br/documentstore/1806-4841/YXkMPPn7DZ7cBZt4rfX9v7w/fdc1fa1f3a40cd5c009751c8260cf5f16e7a6004.jpg)
SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome, Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome,
![SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein](https://onlinelibrary.wiley.com/cms/asset/496e53b8-0be8-4c37-a8b6-305423fc5cf9/ajh26602-fig-0001-m.jpg)
American Journal of Hematology, Blood Research Journal
![SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein](https://minio.scielo.br/documentstore/1806-4841/YXkMPPn7DZ7cBZt4rfX9v7w/314ea03061bf2244fa15944a894ef4dc1f745b75.jpg)
SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome, Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome,
![SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fncomms15837/MediaObjects/41467_2017_Article_BFncomms15837_Fig5_HTML.jpg)
Targeted two-photon chemical apoptotic ablation of defined cell types in vivo
![SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein](https://www.thelancet.com/cms/attachment/3f44d558-cef7-4035-8975-5fbad9d9359e/gr2_lrg.jpg)
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial - The Lancet Neurology
![SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein](https://www.thelancet.com/cms/attachment/9f8d425f-93b6-479d-829f-284ffb7909c1/gr3.jpg)
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet
![SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein](https://www.thelancet.com/cms/attachment/bcc08e72-aa90-4a56-8352-a11345f982b5/gr3.jpg)
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial - The Lancet Neurology
![SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein](https://minio.scielo.br/documentstore/2531-1387/RS75byfw9rMVHz5VXCZdssH/aa1f82c07ed95c2213439ae345b0264ac052fb8f.jpg)
SciELO - Brasil - New proteasome inhibitors in the treatment of multiple myeloma New proteasome inhibitors in the treatment of multiple myeloma
de
por adulto (o preço varia de acordo com o tamanho do grupo)